Laurent Poulain Selected Research

Leukemia

1/2021

Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laurent Poulain Research Topics

Disease

43	Neoplasms (Cancer) 01/2024 - 04/2002
22	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2002
22	Carcinoma (Carcinomatosis) 01/2020 - 01/2002
5	Mesothelioma 02/2015 - 04/2009
3	Chondrosarcoma 01/2023 - 05/2021
3	Adenocarcinoma 05/2022 - 01/2008
3	Testicular Neoplasms (Testicular Cancer) 02/2011 - 09/2008
3	Embryonal Carcinoma 02/2011 - 03/2009
3	Malignant Mesothelioma 06/2010 - 04/2009
2	Osteosarcoma (Osteogenic Sarcoma) 01/2023 - 03/2022
2	Carcinogenesis 11/2022 - 04/2015
2	Stomach Neoplasms (Stomach Cancer) 05/2022 - 03/2011
2	Ovarian Epithelial Carcinoma 01/2022 - 02/2021
2	Prostatic Neoplasms (Prostate Cancer) 07/2020 - 01/2020
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2020 - 01/2020
2	Hypoxia (Hypoxemia) 02/2015 - 09/2012
1	Triple Negative Breast Neoplasms 09/2023
1	Neoplasm Metastasis (Metastasis) 07/2023
1	Squamous Cell Carcinoma of Head and Neck 03/2023
1	Lymphoma (Lymphomas) 03/2022
1	Sarcoma (Soft Tissue Sarcoma) 03/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Thyroid Neoplasms (Thyroid Cancer) 11/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2021
1	Leukemia 01/2021
1	Peritoneal Neoplasms 10/2017
1	Ascites 01/2017

Drug/Important Bio-Agent (IBA)

13	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 01/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2009
8	MicroRNAs (MicroRNA)IBA 11/2023 - 02/2011
8	ABT-737IBA 01/2022 - 04/2013
6	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2013
6	PlatinumIBA 01/2022 - 06/2010
5	Apoptosis Regulatory ProteinsIBA 01/2022 - 04/2013
4	Citric Acid (Citrate)FDA LinkGeneric 10/2013 - 04/2009
4	Glucose (Dextrose)FDA LinkGeneric 02/2012 - 09/2006
4	IntegrinsIBA 02/2011 - 01/2002
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2021 - 01/2020
3	Adenosine Triphosphate (ATP)IBA 03/2011 - 04/2009
3	Integrin alphaVIBA 04/2010 - 01/2002
2	AntigensIBA 12/2023 - 11/2021
2	Long Noncoding RNAIBA 07/2023 - 12/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2023 - 09/2012
2	Fluorouracil (Carac)FDA LinkGeneric 05/2022 - 04/2002
2	LuciferasesIBA 05/2021 - 10/2017
2	naftopidilIBA 07/2020 - 01/2020
2	trametinibIBA 01/2020 - 01/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020 - 01/2017
2	Small Interfering RNA (siRNA)IBA 10/2017 - 02/2015
2	bromopyruvateIBA 02/2012 - 04/2009
2	LipidsIBA 01/2012 - 03/2011
2	PhosphofructokinasesIBA 03/2011 - 04/2009
2	VitronectinIBA 04/2010 - 01/2008
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2024
1	Chimeric Antigen ReceptorsIBA 12/2023
1	Leucovorin (Folinic Acid)FDA Link 05/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2022
1	spartalizumabIBA 05/2022
1	AntibodiesIBA 05/2022
1	Docetaxel (Taxotere)FDA Link 05/2022
1	bcl-2 Homologous Antagonist-Killer Protein (bcl 2 Homologous Antagonist Killer Protein)IBA 03/2022
1	folfirinoxIBA 01/2022
1	navitoclaxIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2021
1	RNA (Ribonucleic Acid)IBA 08/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2021
1	Taxoids (Taxanes)IBA 01/2020
1	SaltsIBA 01/2020
1	carboxyamido-triazole (carboxyamidotriazole)IBA 09/2018
1	atelocollagenIBA 10/2017
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2017
1	Bcl-2-Like Protein 11IBA 01/2017
1	CalciumIBA 04/2015
1	Carboplatin (JM8)FDA LinkGeneric 03/2015
1	Caspase 3 (Caspase-3)IBA 03/2015
1	pyridoclaxIBA 02/2015
1	CollagenIBA 02/2015
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2015
1	High-Temperature Requirement A Serine Peptidase 1IBA 02/2015
1	Collagen Type I (Type I Collagen)IBA 02/2015
1	dactolisibIBA 06/2014
1	3- (3- hydroxy- 4- methoxyphenyl)- 8H- thieno(2,3- b)pyrrolizin- 8- oneIBA 06/2013
1	Platinum Compounds (Compounds, Platinum)IBA 04/2013
1	TOR Serine-Threonine KinasesIBA 01/2013
1	Excipients (Suspending Agents)IBA 01/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2013
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2013
1	Carrier Proteins (Binding Protein)IBA 01/2013

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 05/2022 - 03/2009
9	Therapeutics 11/2022 - 04/2009
7	Precision Medicine 10/2023 - 01/2017
2	Aftercare (After-Treatment) 04/2012 - 02/2011
1	Investigational Therapies (Experimental Therapy) 03/2023
1	Radiotherapy 03/2023
1	Immunotherapy 05/2022
1	Neoadjuvant Therapy 05/2022
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2020
1	Withholding Treatment 01/2013